stroke patients
forms of stroke
PoC plan
high risk
clinical development
business development strategy
complete business plan
acute neurodegenerative conditions Stroke
complete phase
effective treatments
likelihood risk of failure
leading cause of death
leading cause of disability
Proof of principle
drug available
different mechanism of action
competitive analysis
optimal compounds
Foreground analysis
high demand
disease mechanism
different points
fatal bleeding
secondary bleeding
therapeutic principle
man study
man trial
post-proof of concept
class neuroprotective therapy
largest - unmet medical need
course
survival
IPR FTPO
major objectives
blood-clot
neurological outcomes
commercialisation process
ERC-ADG RadMed
brain infarct
criteria
contrast
single compound
work
innovative approach
contra-indications
agent
needed innovation
final step
ambulance
contraindication